Asthma Hospitalizations in Children Before and After COVID-19: Insights from Northern Colombia

Moisés Árquez-Mendoza1, Karen Franco-Valencia1, Marco Anaya-Romero1

  • 1Life Science Research Center, Facultad de Ciencias Básicas y Biomédicas, Universidad Simón Bolívar, Barranquilla 080002, Colombia.

Clinics and Practice
|October 28, 2025
PubMed

Insights

The COVID-19 pandemic impacted pediatric asthma management, affecting hospitalization and corticosteroid use. Factors like nutrition and breastfeeding influenced severity, highlighting the need for tailored care.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Environmental Health

Background:

  • Pediatric asthma is complex, influenced by environmental, biological, and social factors.
  • The COVID-19 pandemic introduced new challenges affecting asthma severity and management in children.
  • Changes in healthcare access, treatment adherence, and environmental exposures were noted.

Purpose of the Study:

  • To assess the association between pediatric asthma severity and factors like nutrition, corticosteroid use, COVID-19 vaccination, and pollutant exposure.
  • To compare these associations before and during the COVID-19 pandemic.
  • To identify predictors of asthma severity in a pediatric cohort.

Main Methods:

  • Retrospective analysis of 307 pediatric medical records (ages 3-17).
  • Data included sociodemographics, nutritional status, corticosteroid use, COVID-19 vaccination, and pollutant exposure.
  • Asthma severity assessed via pulmonary score; Bayesian Logistic Regression Model (BLRM) used for analysis.

Main Results:

  • The pandemic significantly impacted hospitalization rates (p=0.0187) and corticosteroid use (p=0.009).
  • Pre-pandemic, mild vs. severe asthma cases showed geographic differences linked to nutrition and gender (p=0.018).
  • During the pandemic, breastfeeding history, body weight, and hospitalization predicted severity (p<0.05); BLRM confirmed breastfeeding (p=0.022) and hospitalization (p=0.012) association with pulmonary scores.

Conclusions:

  • The pandemic altered the clinical course and management of pediatric asthma.
  • Preventive strategies must integrate nutrition, early-life factors (breastfeeding), and equitable access to care and vaccination.
  • Personalized asthma management considering these variables can improve outcomes and reduce health disparities.

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K